Although SK-216 administration tended to lower type I collagen α1 chain (COL1A1) mRNA levels in lung tissues, the differences between BLM+DW mice and BLM+SK-216 mice did not reach statistical significance (Fig 8A). Here, COL1A1 is linked to Bloom syndrome.